Coronary Calcium Scans: Who Actually Benefits, 10-Year Study Finds

Coronary artery calcium (CAC) scans have become one of the most widely marketed heart tests in preventive medicine. The low-dose CT scan measures calcified plaque in the arteries that feed the heart, producing a single number that patients often interpret as a verdict on their cardiovascular future. New long-term evidence suggests that number is far more useful for some people than others.

In a study following more than 6,000 adults for roughly a decade, researchers compared how well standard risk calculators predicted heart disease with and without the addition of a calcium score. Conventional tools already combine age, sex, blood pressure, cholesterol, smoking status and diabetes to estimate a person's 10-year probability of a heart attack or stroke. Adding the scan improved the overall accuracy of those predictions only modestly across the full study population.

That finding matters because CAC scans are frequently promoted directly to consumers, sometimes at walk-in imaging centers, and are often paid for out of pocket. For a 40-year-old with normal cholesterol and no risk factors, or for a 70-year-old already on aggressive preventive therapy, the scan is unlikely to change what happens next. The treatment plan was largely set by the clinical picture before the scanner was switched on.

Where the scan earns its place

The picture changed for participants whose calculated risk landed in the borderline or intermediate range, generally cited as roughly a 5% to 20% chance of a cardiovascular event over ten years. This is precisely the group where clinicians and patients struggle to decide whether to begin lifelong medication such as a statin. Among these participants, calcium scores separated those who went on to develop heart disease from those who did not with meaningful clarity.

A score of zero in that group was associated with substantially lower event rates over the following decade, supporting a decision to delay drug therapy and focus on lifestyle measures. Elevated scores, by contrast, identified people whose arteries were already accumulating disease despite unremarkable lab values, strengthening the case for earlier and more intensive treatment.

Interpreting the numbers

Calcium scores are typically grouped into broad bands:

• Zero: no detectable calcified plaque, generally indicating low short-term risk
• 1 to 99: mild plaque burden
• 100 to 399: moderate plaque burden
• 400 or higher: extensive plaque, usually prompting aggressive risk-factor management

An important caveat is that the scan detects calcified plaque only. Softer, non-calcified plaque, which can also rupture and cause heart attacks, does not register. A zero score therefore lowers estimated risk but does not eliminate it, particularly in younger adults, smokers, or people with strong family histories.

The practical takeaway is one of targeting rather than rejection. The study does not argue that calcium scanning lacks value; it argues that value is concentrated in a specific decision point. Ordering the test broadly adds radiation exposure, cost and the possibility of incidental findings that trigger further testing, without a corresponding gain in predictive power.

For patients, the most useful step is to ask for a standard risk estimate first. If that number sits comfortably low or unambiguously high, a scan will likely confirm what is already known. If it falls in the uncertain middle, a calcium score may be the piece of information that finally settles the question of whether to start treatment now or wait.